Fitbit data indicates that people who contracted Covid-19 have long-term behavioral and psychological symptoms—including elevated heart rates—and these symptoms endure for months longer than do similar symptoms in people suffering from other respiratory illness, according to a new JAMA study.
While overall cancer death rate for men and women fell between 2014 and 2018, fatality rates for a handful of cancers increased—or stalled after recent improvements, according to a new report from the National Cancer Institute. See the trends, charted.
A study published in Pediatrics suggests that childhood obesity increased during the pandemic—likely because of children having to stay at home, as well as other societal conditions surrounding Covid-19 shutdowns, Kim Tingley reports for the New York Times Magazine.
Pfizer and BioNTech on Thursday announced they will seek FDA authorization of a booster shot of their Covid-19 vaccine, but several infectious disease experts said booster shots may not be necessary—at least not yet.
Johnson & Johnson plans to begin its first vaccine study on adolescents in the fall, a study finds lotteries have little effect on increasing vaccination rates, and more in this week's roundup of Covid-19 news.
On Thursday, FDA narrowed its approval for Biogen's Alzheimer's drug Aduhelm to only patients with early-stage symptoms of the disease, in today's bite-sized hospital and health industry news from Maryland and Missouri.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.